Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese

Breadcrumb

  1. Home
  2. Microbiota 15 - April 2022
  3. Microbiota in Covid-19 pandemic
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
General Medicine

Breadcrumb

  1. Home
  2. Microbiota 15 - April 2022
  3. Microbiota in Covid-19 pandemic
Gastroenterology

Microbiota in Covid-19 pandemic

Covid-19

Overview

By Pr. Conceição Calhau
NOVA Medical School, New University of Lisbon, Portugal
By Pr. Pedro Povoa
NOVA Medical School, New University of Lisbon, Portugal; Polyvalent Intensive Care Unit, Hospital São Francisco Xavier, CHLO, Lisbon, Portugal; Center for Clinical Epidemiology, OUH Odense, University Hospital, Denmark

Gastroenterology
Gynecology
Pediatrics
General Medicine
  • Our publications
    • News
    • Microbiota Mag
    • Thematic pages
    • Experts' point of view
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • About us
    • International Microbiota Observatory
    • Press room
    • Partnerships
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
  • Useful documents
    • How to talk about
    • Infographics
    • IBS Diagnosis Check List
    • Patients Stories

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Sections

About this article

Created 22 April 2022
Updated 20 July 2022

For the first time, the gut microbiota diversity is pointed out as a prognostic biomarker of Covid-19 severity. Thus, the microbiota changes as reliable biomarkers in the context of Covid-19 represent a key piece of the disease puzzle, thus highlighting the clinical priority for prevention and possibly new therapeutic strategies. In 2020, the new coronavirus severely affected certain groups of the population, more specifically, the elderly and people with obesity, hypertension, diabetes [1]. Interestingly, publications showed that dysbiosis is a common factor in all these patients [2, 3].

GUT MICROBIOTA SIGNATURES IN COVID-19 PATIENTS

As gut microbiota has been considered a hot topic in the scientific community with a pivotal role on host immune and inflammatory functions, we investigated if changes in gut microbiota composition are associated with an increased clinical severity of Covid-19 [4]. A national multicenter cross-sectional study was conducted in 115 Covid-19 patients categorized by: 1) location of recovery from Covid-19: ambulatory (household isolation), ward or intensive care unit; and 2) Covid-19 severity scale: asymptomatic/mild-to-moderate or severe. Severely ill patients exhibited profound changes in gut microbiota composition compared with mild-to-moderate patients in ambulatory or admitted to the hospital ward (Figure 1). These changes included: 1) lower overall gut microbial diversity; 2) lower abundance of beneficial butyrate-producing bacteria such as Roseburia and Lachnospira; 3) lower Firmicutes/ Bacteroidetes ratio; 4) higher abundance of Proteobacteria. In addition, we detected the virus in fecal samples, which must be considered in public health recommendations [5, 6] Publications from other colleagues have shown that low diversity could be a clinical biomarker predicting greater risk of severity [7-9].

Image
Image

RESPIRATORY MICROBIOTA IN COVID-19 CRITICALLY ILL PATIENTS

The conventional wisdom was that the healthy lungs were sterile. In the last decade, the application of techniques of microbiota research clearly showed that was not the case. The lungs are colonized by a very low bacterial load compared with the gut [10]. The different parts of the respiratory tract (oropharynx, airway, lungs) present different diversity and compositions related to the colonization sources, colonization rates, extinction rates and distances between each other according to the adapted island model, being the “mainland” the oral cavity [11]. Recent studies in severe Covid-19 patients showed dysbiosis of the airway microbiota (analyzed in BALF samples) similar to the dysbiosis observed during lower respiratory tract infections, pneumonia for example [12, 13]. In addition, Acinetobacter – a common gram-negative non-fermenting bacilli pathogen of ventilator-associated pneumonia that is the most severe ICU-acquired infection in patients undergoing invasive mechanical ventilation – was a common bacterial genus found in lung tissues in deceased patients [14]. The presence of some pathogens in the lung of deceased patients and in the oral cavity is related to the adapted island model migration [15]. As a result of the Covid- 19 associated immune dysregulation, several epidemiologic studies showed an increased risk of hospital acquired infections, namely ventilator associated pneumonia as our group showed. In our study we found that Covid-19 patients presented twice the risk of ventilator associated pneumonia in comparison to non-Covid-19 patients [16].

Conclusion

Microbiota and Covid-19 studies may open perspectives for the development of therapeutic interventions (probiotics, prebiotics…) that aim to correct dysbiosis observed in severe Covid-19 patients. These interventions are expected to increase overall bacterial diversity and the abundance of commensal bacteria, thereby contributing to inhibit the overgrowth of opportunistic pathogens. These studies could also have implications in the design of effective Covid-19 vaccines, as one factor known to control vaccine efficacy could be the gut microbiota.

Sources

1 Petrakis D, Margină D, Tsarouhas K, et al. Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality. Mol Med Rep 2020; 22: 9-19.

2 Finlay BB. Are noncommunicable diseases communicable? Science 2020; 367: 250-1.

3 Leocádio PCL, Oriá RB, Crespo-Lopez ME. Obesity: More Than an Inflammatory, an Infectious Disease? Front Immunol 2019; 10: 3092.

4 Moreira-Rosário A, Marques C, Pinheiro H, et al. Gut microbiota diversity and c-reactive protein are predictors of disease severity in COVID-19 patients. Front Microbiol 2021; 12: 705020.

5 Guo M, Tao W, Flavell RA, et al. Potential intestinal infection and faecal-oral transmission of SARS-CoV-2. Nat Rev Gastroenterol Hepatol 2021; 18: 269-83.

6 Wu Y, Guo C, Tang L, et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 2020; 5: 434-5.

7 Gu S, Chen Y, Wu Z, et al. Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clin Infect Dis 2020; 71: 2669-78.

8 Yeoh YK, Zuo T, Lui GC-Y, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 2021 70, 698–706.

9 Zuo T, Liu Q, Zhang F, et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut 2021; 70: 276-84.

10 Roux D, van Oort PM, Ricard JD, et al. Airway microbiome research: a modern perspective on surveillance cultures? Ann Transl Med 2017; 5: 445.

11 Whiteson KL, Bailey B, Bergkessel M, et al. The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography. Am J Respir Crit Care Med 2014; 189: 1309-15.

12 Shen Z, Xiao Y, Kang L, et al. Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019. Clin Infect Dis 2020; 71: 713-20.

13 Yamamoto S, Saito M, Tamura A, et al. The human microbiome and COVID-19: A systematic review. PLoS One 2021; 16: e0253293.

14 Fan J, Xiang L, Gao Y, et al. The lung tissue microbiota features of 20 deceased patients with COVID-19. J Infect 2020; 81: e64-7.

15 Battaglini D, Robba C, Fedele A, et al. The role of dysbiosis in critically ill patients with Covid-19 and acute respiratory distress syndrome. Front Med 2021; 8: 671714.

16 Rouzé A, Martin-Loeches I, Povoa P, et al. Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study. Intensive Care Med 2021; 47: 188-98.

Tags
Covid-19 SARS-CoV-2 Gut Overview Microbiome Flora
    Focus
    Microbiota 15 - April 2022
    • Overview
      • New perspectives in autism: the role of microbiota in social communication
      • Microbiota in Covid-19 pandemic
    • Commented article
      • Commensal clostridiales strains mediate effective anti-cancer immune response against solid tumours
      • Early-life formula feeding is associated with gut microbiota alterations and increased antibiotic resistance in infants
    • Congress review
      • Microbiome topics at GASTRO 2021
    • Press review
      • Gut Microbiota #15
      • Vaginal Microbiota #15
    • Expert opinion
      • The blue poop challenge a reliable method to evaluate gut transit?
    Created 22 April 2022
    Updated 20 July 2022

    About this article

    To know more about this topic.

    Main topic

    Covid-19

    Content type

    Article
    New perspectives in autism: the role of microbiota in social communication
    Commensal clostridiales strains mediate effective anti-cancer immune response against solid tumours
    Focus

    Microbiota 15 - April 2022

    Overview

    New perspectives in autism: the role of microbiota in social communication Microbiota in Covid-19 pandemic

    Commented article

    Commensal clostridiales strains mediate effective anti-cancer immune response against solid tumours Early-life formula feeding is associated with gut microbiota alterations and increased antibiotic resistance in infants

    Congress review

    Microbiome topics at GASTRO 2021

    Press review

    Gut Microbiota #15 Vaginal Microbiota #15

    Expert opinion

    The blue poop challenge a reliable method to evaluate gut transit?
    Gastroenterology
    Actu PRO : Malnutrition : agir sur le microbiote pour améliorer la croissance, un prototype à l’essai
    08.07.2021

    Malnutrition: acting on the microbiota in order to improve growth, a trial prototype

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    07.02.2025

    Your functional dyspepsia diagnosis check list

    Read the article
    17.04.2025

    Sensitivity to the additive E466: the role of the microbiota

    Read the article
    Photo HCPs: Clinical context over quick fix: the fresh consensus on microbiome testing
    11.04.2025

    Clinical context over quick fix: the fresh consensus on microbiome testing

    Read the article
    22.11.2023

    Is vaginal microbiota transfer the new miracle for C-section babies?

    Read the article
    Actu PRO : Alcoolisme : expliquer les troubles sociaux grâce au microbiote
    27.01.2021

    Alcoholism: explaining social disorders thanks to the microbiota

    Read the article

    Association between fungal dysbiosis and environment

    The fungal portion of the gut microbiota (or mycobiota) has been much less studied than the bacterial...

    Find out more
    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine
    • English
    • Français
    • Español
    • Russian
    • Portuguese

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    14.05.2025

    Towards worldwide redefinition of healthy vaginal microbiota

    Read the article
    07.05.2025

    The microbial-metabolic nexus in colon cancer

    Read the article
    02.05.2025

    A new lens on chlamydia: beyond behavior, into the microbiome

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic pages
      • Experts' point of view
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • About us
      • International Microbiota Observatory
      • Press room
      • Partnerships
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
    • Useful documents
      • How to talk about
      • Infographics
      • IBS Diagnosis Check List
      • Patients Stories

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube
      • Instagram
      • Bluesky

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    General Medicine

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • Instagram
    • Bluesky

    © 2025 Biocodex. All rights reserved.

    • Legal notice
    • GTU
    • Data protection policy
    • Sitemap
    • Cookies settings
    • Digital accessibility : partially compliant
    Biocodex logo